候选抗疟疾化合物MMV367的首次在人体上的安全性,耐受性,药理动力学和试点食品效应研究
Andrea Kuemmerle1, Nand Singh2, Denis Gossen3
1MMV Medicines for Malaria Venture, Geneva, Switzerland.
British journal of clinical pharmacology
|May 29, 2025
概括
新型抗疟疾药物MMV367在健康参与者中显示出良好的安全性和耐受性. 它的药理动力学特征支持疟疾治疗的进一步发展.
科学领域:
- 药理学和热带医学 热带医学
- 药物开发 药物开发
- 临床试验 临床试验
背景情况:
- 疟疾仍然是一个重大的全球健康威胁,需要新的治疗药物.
- MMV367是一种新的抗疟疾药物,向Plasmodium falciparum乙烯共酶A合成酶10/11.
研究的目的:
- 在健康个体中评估口服MMV367的安全性,耐受性和药理动力学.
- 确定MMV367.7的初始人类安全和剂量参数.
主要方法:
- 这是一项首次对人类进行的随机,双盲,安慰剂控制的研究,涉及47名健康参与者.
- 在禁食状态下单次上升剂量 (100-1500毫克),食物效应研究 (440毫克) 和为期3天的多重上升剂量研究 (400毫克每天一次).
主要成果:
- 总体而言,MMV367耐受性良好,治疗引起的不良事件发生率低 (36.8%与安慰剂44.4%相比).
- 没有观察到严重的不良事件或临床显著的生命体征,心电图或实验室测试的变化.
- 已证明与剂量成比例的药理动力学,半衰期为16.5-18.4小时,与食物一起服用时可增加生物可用性.
结论:
- 在健康参与者中,MMV367表现出可接受的安全性和耐受性.
- MMV367的药理动力学特征支持其作为潜在的抗疟疾药物的持续发展.
更多相关视频
09:04In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
6.6K
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
3.1K
相关概念视频
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
